IP Library Granted Patent US 11,304,965
Granted Patent B2
US 11,304,965 · App. 17/083,112 · Granted Apr 19, 2022

Flavonoid compositions and related methods

Inventors: Catherina C. Caballero-George (Panama, PA); Andres Rivera Mondragon (Panama, PA)
Assignee: Instituto de Investigaciones Cientificas y Servicios de Alta Tecnologia
A61K31/7016A61K31/216A61K31/7048A61K36/185A61P9/08A61P9/12A61K2236/15A61K2236/33
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,304,965
App. No.
17/083,112
Granted
Apr 19, 2022
Kind
B2
Abstract

Flavonoids that are isolated from plant material of the genus Cecropia can be used to perturb G-protein coupled receptors in a mammalian cell. In some instances, one or more flavonoids may interact with one or more of the G-protein coupled receptors to transiently increase the concentration of cytosolic calcium. Administration of the isolated flavonoids can be used to treat hypertension, to protect the integrity of blood vessels and related conditions.

Claims (18)

1. A method for producing a formulation for administration to a mammalian subject, the method comprising:

mixing plant material with an alcohol, wherein the plant material is from one or more plants belonging to the Cecropia genus;

extracting a portion of the plant material into the alcohol;

isolating the extracted portion of plant material from a remainder of the plant material;

removing at least a portion of the isolated extracted portion of the plant material to obtain a first composition, wherein the first composition comprises two or more flavonoids, the two or more flavonoids in the first composition being selected from the group consisting of isovitexin-2″-O-rhamnoside, isovitexin-2″-O-glucoside, isovitexin-2″-O-xyloside, isovitexin-O-xyloside, isoorientin-2″-O-xyloside, and mixtures thereof; and

combining the first composition with a second composition to form the formulation for administration to the mammalian subject.

2. The method of claim 1 , wherein the two or more flavonoids collectively (1) antagonize the angiotensin II receptor, type 1, (2) agonize the angiotensin II receptor, type 2, and (3) agonize the endothelin receptor type B.

3. The method of claim 1 , wherein the alcohol has four or fewer carbon atoms.

4. The method of claim 1 , wherein the alcohol is methanol.

5. The method of claim 1 , wherein the extracted portion is further washed with a solvent comprising dichloromethane.

6. The method of claim 1 , wherein the extracted portion is further washed with a solvent comprising hexane.

7. The method of claim 1 , wherein the isolating the extracted portion of plant material is carried out via chromatography.

8. The method of claim 1 , wherein the plant material is macerated prior to extracting a portion of the plant material into one or more organic solvents.

9. The method of claim 1 , wherein the two or more flavonoids are between 0.3% and 15% of the formulation by weight.

10. The method of claim 1 , wherein the plant material is exclusively from aerial parts of the plant.

11. The method of claim 1 , wherein the formulation lowers blood pressure when administered to the mammalian subject.

12. The method of claim 1 , wherein one or more plants belong to the species Cecropia obtusifolia.

13. The method of claim 1 , wherein the second composition comprises a dispersant, a humectant, a carrier, an antistatic agent, a filler, a diluent, or any combination thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2020
From: CABALLERO-GEORGE, CATHERINA C.; RIVERA MONDRAGON, ANDRES
To: INSTITUTO DE INVESTIGACIONES CIENTIFICAS Y SERVICIOS DE ALTA TECNOLOGIA (INDICASAT AIP)
Reel/Frame 054207/0503 →
Continuity (3)
Continuation 15884118 · Jan 30, 2018
Provisional Application 62453928 · Feb 2, 2017
Related Publication 20210106600A1 · Apr 15, 2021